术前贝伐珠单抗用于增殖性糖尿病视网膜病变牵拉性视网膜脱离:一项前瞻性随机临床试验
这项前瞻性、双盲、随机、多中心、阳性对照临床试验纳入224例(224眼)增殖性糖尿病视网膜病变牵拉性视网膜脱离患者,比较小切口玻璃体切割术(PPV)联合术前玻璃体腔注射1.25 mg贝伐珠单抗(IVB)与单纯PPV。结果显示研究组医源性视网膜裂孔、2级术中出血及需内电凝的比例均低于对照组,平均手术时间两组差异未达统计学显著。作者认为术前IVB似乎可减少术中出血、改善手术视野并减少术中及术后并发症。
要点
- 研究组医源性视网膜裂孔35眼(34.3%)低于对照组66眼(58.9%)(P = .001)。
- 研究组2级术中出血32眼(31.3%)低于对照组58眼(51.7%)(P = .001)。
- 研究组需内电凝28眼(27.4%)低于对照组75眼(66.9%)(P = .0001)。
核心结论
- 作者认为术前玻璃体腔注射贝伐珠单抗似乎可减少术中出血、改善手术视野可视化,并减少术中及术后并发症。
研究设计与样本
- 前瞻性、双盲、随机、多中心、阳性对照临床试验,2013年11月至2015年7月纳入224例患者的224眼。
- 所有眼均接受基线检查,包括最佳矫正视力、彩色照相、光学相干断层扫描和荧光素血管造影。
- 214例患者(214眼)按1:1随机分为PPV联合IVB组(研究组)102眼和PPV联合假注射组(对照组)112眼。
- 收集术中出血、总手术时间、术后早期(<1个月)玻璃体出血及12个月时最佳矫正视力平均变化的数据,P < .05认为有统计学显著意义。
主要发现
- 术中医源性视网膜裂孔研究组35眼(34.3%) vs 对照组66眼(58.9%)(P = .001)。
- 术中2级出血研究组32眼(31.3%) vs 对照组58眼(51.7%)(P = .001)。
- 需内电凝研究组28眼(27.4%) vs 对照组75眼(66.9%)(P = .0001)。
- 平均手术时间研究组71.3 ± 32.1分钟 vs 对照组83.6 ± 38.7分钟(P = .061),两组差异未达统计学显著。
临床怎么用
- 原文结论未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess the effectiveness and safety of an intravitreal injection of 1.25 mg bevacizumab (IVB) as a preoperative adjunct to small-gauge pars plana vitrectomy (PPV) compared with PPV alone in eyes with tractional retinal detachment secondary to proliferative diabetic retinopathy. METHODS: This prospective, double-masked, randomized, multicenter, active-controlled clinical trial enrolled 224 eyes of 224 patients between November 2013 and July 2015. All eyes underwent a baseline examination including best-corrected visual acuity, color photos, optical coherence tomography, and fluorescein angiography. Data were collected on intraoperative bleeding, total surgical time, early (<1 month) postoperative vitreous hemorrhage, and mean change in best-corrected visual acuity at 12 months. P < .05 was considered statistically significant. RESULTS: A total of 214 patients (214 eyes) were randomized in a 1:1 ratio to PPV plus IVB ([study group] 102 eyes) or PPV plus sham ([control] 112 eyes). Iatrogenic retinal breaks were noted intraoperatively in 35 eyes (34.3%) in the study group, and 66 eyes (58.9%) in the control group (P = .001). Grade 2 intraoperative bleeding was noted in 32 (31.3%) eyes in the study group and 58 (51.7 %) eyes in the control group (P = .001). Endodiathermy was necessary in 28 (27.4 %) eyes in the study group, compared with 75 (66.9%) eyes in the control group (P = .0001). Mean surgical time was 71.3 ± 32.1 minutes in the study group and 83.6 ± 38.7 minutes in the control group (P = .061). CONCLUSION: Preoperative IVB seems to reduce intraoperative bleeding, improving surgical field visualization, and reducing intraoperative and postoperative complications. NOTE: Publication of this article is sponsored by the American Ophthalmological Society.
引用
- Arevalo JF, Lasave AF, Kozak I, et al. Preoperative Bevacizumab for Tractional Retinal Detachment in Proliferative Diabetic Retinopathy: A Prospective Randomized Clinical Trial. Am J Ophthalmol. 2019. PMID: 31095954. doi:10.1016/j.ajo.2019.05.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。